The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 295.00
Bid: 290.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.448%)
Open: 295.00
High: 295.00
Low: 295.00
Prev. Close: 295.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: Notification of major holdings

29 Jan 2024 16:52

RNS Number : 2701B
MaxCyte, Inc.
29 January 2024
 

TR-1: Notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

MAXCYTE INC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

BlackRock, Inc.

City and country of registered office (if applicable)

Wilmington, DE, USA

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

25/01/2024

6. Date on which issuer notified (DD/MM/YYYY):

26/01/2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

7.93%

0.28%

8.22%

8,551,167

Position of previous notification (if

applicable)

7.07%

0.18%

7.25%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

US57777K1060

8,253,169

7.93%

SUBTOTAL 8. A

8,253,169

7.93%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Securities Lending

N/A

N/A

297,998

0.28%

SUBTOTAL 8. B 1

297,998

0.28%

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock, Inc.

Trident Merger, LLC

BlackRock Investment Management, LLC

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Holdco 3, LLC

BlackRock Cayman 1 LP

BlackRock Cayman West Bay Finco Limited

BlackRock Cayman West Bay IV Limited

BlackRock Group Limited

BlackRock Finance Europe Limited

BlackRock Investment Management (UK) Limited

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Holdco 4, LLC

BlackRock Holdco 6, LLC

BlackRock Delaware Holdings Inc.

BlackRock Institutional Trust Company, National Association

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Holdco 4, LLC

BlackRock Holdco 6, LLC

BlackRock Delaware Holdings Inc.

BlackRock Fund Advisors

3.74%

0.26%

4.01%

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Holdco 3, LLC

BlackRock Canada Holdings LP

BlackRock Canada Holdings ULC

BlackRock Asset Management Canada Limited

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Capital Holdings, Inc.

BlackRock Advisors, LLC

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Holdco 3, LLC

BlackRock Cayman 1 LP

BlackRock Cayman West Bay Finco Limited

BlackRock Cayman West Bay IV Limited

BlackRock Group Limited

BlackRock Finance Europe Limited

BlackRock Advisors (UK) Limited

BlackRock, Inc.

Trident Merger, LLC

BlackRock Investment Management, LLC

Amethyst Intermediate, LLC

Aperio Holdings, LLC

Aperio Group, LLC

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

BlackRock Regulatory Threshold Reporting Team Jana Blumenstein

020 7743 3650

 

 

Place of completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

Date of completion

26 January 2024

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBLMFTMTITBPI
Date   Source Headline
10th Apr 20241:05 pmRNSNotice of Results
3rd Apr 20247:00 amRNSTotal Voting Rights and Block Listing Return
2nd Apr 20241:05 pmRNSSigning of Strategic Platform License
2nd Apr 20247:00 amRNSExercise of options and PDMR dealing
20th Mar 202410:16 amRNSGrant of Options, RSUs and PSUs and PDMR Dealing
20th Mar 202410:05 amRNSGrant of Options, RSUs and PSUs and PDMR Dealing
13th Mar 20247:05 amRNSFiling of form 10-K for FY ended December 31, 2023
13th Mar 20247:00 amRNSReports Q4 & FY 2023 Financial Results
6th Mar 20248:58 amRNSTR-1: Notification of major holdings
5th Mar 20247:00 amRNSPreliminary FY Results & 2024 Guidance
1st Mar 20245:57 pmRNSTotal Voting Rights
29th Feb 20249:21 amRNSExercise of options and PDMR dealing
26th Feb 20247:00 amRNSTR-1: Notification of major holdings
9th Feb 20241:05 pmRNSNotice of Results
1st Feb 20249:24 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
30th Jan 20242:29 pmRNSHolding(s) in Company
30th Jan 20241:05 pmRNSSigning of Strategic Platform License
29th Jan 20244:52 pmRNSTR-1: Notification of major holdings
29th Jan 20247:00 amRNSFiling of Form 8-K
23rd Jan 20241:05 pmRNSSigning of Strategic Platform License
9th Jan 20247:00 amRNSPreliminary Unaudited Q4 and FY 2023 Results
5th Jan 20247:00 amRNSGrant of Options and PDMR Dealing
3rd Jan 20241:05 pmRNSSigning of Strategic Platform License
2nd Jan 20249:23 amRNSTotal Voting Rights
2nd Jan 20247:00 amRNSConfirmation of Board change
29th Dec 20237:00 amRNSExercise of options and PDMR dealing
12th Dec 20237:00 amRNSCEO Transition and Revenue Guidance Update
7th Dec 20239:50 amRNSExercise of options and PDMR dealing
4th Dec 20237:00 amRNSExercise of options and PDMR dealing
1st Dec 20235:43 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of options and PDMR dealing
17th Nov 20237:00 amRNSExercise of options and PDMR dealing
16th Nov 20231:05 pmRNSMaxCyte Joins the Alliance for mRNA Medicines
9th Nov 20237:01 amRNSFiling of Form 10-Q
9th Nov 20237:00 amRNSThird Quarter Results
7th Nov 20237:00 amRNSParticipation in Upcoming Investor Conferences
1st Nov 20231:12 pmRNSTotal Voting Rights
5th Oct 20237:00 amRNSPreliminary Q3 Revenue & FY Revenue Guidance
2nd Oct 20234:03 pmRNSTotal Voting Rights
13th Sep 20232:28 pmRNSTR-1: Notification of major holdings
12th Sep 20231:21 pmRNSTR-1: Notification of major holdings
5th Sep 20234:17 pmRNSTR-1: Notification of major holdings
5th Sep 20231:05 pmRNSBaird Global Healthcare Conference Participation
4th Sep 20231:32 pmRNSTR-1: Notification of major holdings
4th Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20239:01 amRNSExercise of options and PDMR dealing
18th Aug 20235:25 pmRNSTR-1
17th Aug 20234:27 pmRNSTR-1: Notification of major holdings
17th Aug 20237:00 amRNSTR-1: Notification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.